SOPs for Pharmacovigilance

The purpose of this SOP is to define the procedures for coding pharmacovigilance data to ensure standardized and accurate classification of safety information.
Click to read the full article.

The purpose of this SOP is to establish standardized procedures for reviewing the quality of pharmacovigilance data to ensure accuracy, completeness, and consistency in safety reporting.
Click to read the full article.

The purpose of this SOP is to define the procedures for managing pharmacovigilance databases to ensure data integrity, security, and accessibility for safety monitoring and reporting.
Click to read the full article.

The purpose of this SOP is to define the procedures for processing pharmacovigilance cases to ensure timely and accurate reporting of adverse events and other safety information.
Click to read the full article.

The purpose of this SOP is to establish standardized procedures for the intake of pharmacovigilance cases to ensure timely and accurate initial data capture for adverse event reports and other safety information.
Click to read the full article.

The purpose of this SOP is to establish procedures for the assessment of pharmacovigilance cases to ensure accurate evaluation of adverse event reports and other safety information.
Click to read the full article.

The purpose of this SOP is to establish standardized procedures for writing case narratives in pharmacovigilance to ensure clear, concise, and accurate documentation of adverse event reports.
Click to read the full article.

The purpose of this SOP is to establish standardized procedures for conducting follow-up activities for pharmacovigilance cases to ensure comprehensive data collection and accurate case assessment.
Click to read the full article.

The purpose of this SOP is to establish standardized procedures for entering pharmacovigilance data to ensure accuracy, consistency, and completeness in the pharmacovigilance database.
Click to read the full article.

The purpose of this SOP is to establish standardized procedures for expedited reporting of serious adverse events (SAEs) to regulatory authorities to ensure timely communication and compliance with regulatory requirements.
Click to read the full article.